A fully automated microfluidic PCR-array system for rapid detection of multiple respiratory tract infection pathogens
- PMID: 33492406
- PMCID: PMC7829496
- DOI: 10.1007/s00216-021-03171-4
A fully automated microfluidic PCR-array system for rapid detection of multiple respiratory tract infection pathogens
Abstract
Rapid and accurate identification of respiratory tract infection pathogens is of utmost importance for clinical diagnosis and treatment, as well as prevention of pathogen transmission. To meet this demand, a microfluidic chip-based PCR-array system, Onestart, was developed. The Onestart system uses a microfluidic chip packaged with all the reagents required, and the waste liquid is also collected and stored on the chip. This ready-to-use system can complete the detection of 21 pathogens in a fully integrated manner, with sample lysis, nucleic acid extraction/purification, and real-time PCR sequentially implemented on the same chip. The entire analysis process is completed within 1.5 h, and the system automatically generates a test report. The lower limit-of-detection (LOD) of the Onestart assay was determined to be 1.0 × 103 copies·mL-1. The inter-batch variation of cycle threshold (Ct) values ranged from 0.08% to 0.69%, and the intra-batch variation ranged from 0.9% to 2.66%. Analytical results of the reference sample mix showed a 100% specificity of the Onestart assay. The analysis of batched clinical samples showed consistency of the Onestart assay with real-time PCR. With its ability to provide rapid, sensitive, and specific detection of respiratory tract infection pathogens, application of the Onestart system will facilitate timely clinical management of respiratory tract infections and effective prevention of pathogen transmission. Onestart, a ready-to-use system, can detect 21 pathogens in a fully integrated manner on a microchip within 1.5 h.
Keywords: Automation; Microfluidic; Multiplex detection; Point-of-care testing; Rapid diagnosis; Respiratory tract infection.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
References
-
- DeGeorge KC, Ring DJ, Dalrymple SN. Treatment of the common cold. Am Fam Physician. 2019;100(5):281–289. - PubMed
MeSH terms
Substances
Grants and funding
- 81871726/National Natural Science Foundation of China
- PT81871726/the Science Foundation of Guangzhou First People's Hospital
- 2019PY14/the Fundamental Research Funds for the Central Universities
- 2020A1515010935/Natural Science Foundation of Guangdong Province
- 201904010413/Guangzhou Science and Technology Program key projects
LinkOut - more resources
Full Text Sources
Other Literature Sources
